Erectile dysfunction and cirrhosis: prevalence and a potential therapy David H. Van Thiel Editorial 30 March 2023 Pages: 277 - 278
Another prognostic marker for hepatocellular carcinoma Yu-Yun Shao Editorial 31 March 2023 Pages: 279 - 280
Comparison of hepatitis B virus reactivation in hepatocellular carcinoma patients who received tyrosine kinase inhibitor alone or together with programmed cell death protein-1 inhibitors Jin LeiTao YanYinying Lu Original Article 29 December 2022 Pages: 281 - 290
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan Chen-Hua LiuCheng-Yuan PengJia-Horng Kao Original Article 26 January 2023 Pages: 291 - 302
Association of age at first birth and risk of non-alcoholic fatty liver disease in women: evidence from the NHANES Huan-Huan YangGuo-Chong ChenZhi-Hui Li Original Article 13 October 2022 Pages: 303 - 312
Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people Xiaopeng ZhuQingxia HuangMingfeng Xia Original Article 03 November 2022 Pages: 313 - 325
Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study Lanlan ChenZhongqi FanGuoyue Lv Original Article 10 November 2022 Pages: 326 - 338
Fully connected neural network-based serum surface-enhanced Raman spectroscopy accurately identifies non-alcoholic steatohepatitis Feng GaoDe-Chan LuCHESS-MAFLD consortium Original Article 11 November 2022 Pages: 339 - 349
Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications Yu-Ming ChengChia-Chi WangJia-Horng Kao Original Article 05 December 2022 Pages: 350 - 356
Liver fibrosis is associated with impaired bone mineralization and microstructure in obese individuals with non-alcoholic fatty liver disease Ilaria BarchettaCarla LubranoMaria Gisella Cavallo Original Article 15 December 2022 Pages: 357 - 366
Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study Seung Mi LeeGeum Joon ChoJoong Shin Park Original Article 21 December 2022 Pages: 367 - 376
HMGCL-induced β-hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4-mediated ferroptosis susceptibility Xiaohan CuiXiao YunWenbin Yu Original Article Open access 12 December 2022 Pages: 377 - 392
Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence Huizhong ShiWenwen ZhangShichun Lu Original Article 23 December 2022 Pages: 393 - 405
Adjuvant anti-PD-1 antibody for hepatocellular carcinoma with high recurrence risks after hepatectomy Wei ChenShuifang HuZhenwei Peng Original Article 16 January 2023 Pages: 406 - 416
Predictive power of portal pressure gradient remeasured shortly after transjugular intrahepatic portosystemic shunt Li MaJingqin MaZhiping Yan Original Article 02 November 2022 Pages: 417 - 426
Distinct course of portal hypertension in patients with cirrhosis with gastric variceal bleeding as their first decompensation: a propensity score-matched study Sanchit SharmaSamagra AgarwalAnoop Saraya Original Article 19 December 2022 Pages: 427 - 433
Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial Rakesh Kumar JagdishAhmed KamaalShiv K. Sarin Original Article 14 November 2021 Pages: 434 - 451
Prevalence and risk factors of erectile dysfunction in patients with liver cirrhosis: a systematic review and meta-analysis Hye Jin YooBora LeeJeong-Ju Yoo Original Article 20 November 2021 Pages: 452 - 462
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression Jiannan QiuShasha WuChunping Jiang Original Article Open access 24 August 2022 Pages: 463 - 475
PIRO-CIC model can predict mortality and futility of care in critically ill cirrhosis patients in the intensive care unit Rakhi MaiwallSamba Siva Rao PasupuletiShiv Kumar Sarin Original Article 13 October 2022 Pages: 476 - 487
Comparison of the prognostic models for mortality in idiosyncratic drug-induced liver injury Yan WangCailun ZouXinyan Zhao Original Article 03 November 2022 Pages: 488 - 498
Good outcomes of living donor liver transplant in primary sclerosing cholangitis: an experience from North India Shekhar Singh JadaunRohit MehtaniSanjiv Saigal Original Article 14 November 2022 Pages: 499 - 506
MAFLD: perceived stigma—a single-center Mexican patient survey Nahum Méndez-SánchezShreya C. PalJorge Alberto Prado-Robles Letter to the Editor 06 December 2022 Pages: 507 - 508
Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies Chia-Yu ChiuKrina PatelHarrys A. Torres Letter to the Editor 07 December 2022 Pages: 509 - 511
Developing real-world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond Teh-Ia HuoJia-I LiaoShu-Yein Ho Letter to the Editor 24 December 2022 Pages: 512 - 513
Reflections on prediction of microvascular invasion in hepatocellular carcinoma by pathology images Wen-Tao CaiNing-Zhe ShenXiao-Dong Chen Letter to the Editor 30 January 2023 Pages: 514 - 515
Correction to: HMGCL‑induced β‑hydroxybutyrate production attenuates hepatocellular carcinoma via DPP4‑mediated ferroptosis susceptibility Xiaohan CuiXiao YunWenbin Yu Correction Open access 13 January 2023 Pages: 516 - 516
